GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $485,000 | +98.8% | 11,049 | +100.0% | 0.02% | 0.0% |
| Q4 2021 | $244,000 | +18.4% | 5,524 | +2.5% | 0.02% | 0.0% |
| Q3 2021 | $206,000 | -10.0% | 5,388 | -6.4% | 0.02% | -27.3% |
| Q2 2021 | $229,000 | +12.8% | 5,758 | +4.2% | 0.03% | -17.5% |
| Q4 2020 | $203,000 | -38.1% | 5,526 | -20.8% | 0.04% | -55.6% |
| Q4 2019 | $328,000 | +10.4% | 6,973 | +0.3% | 0.09% | -6.2% |
| Q3 2019 | $297,000 | +6.1% | 6,955 | -0.5% | 0.10% | +15.7% |
| Q2 2019 | $280,000 | -0.4% | 6,990 | +4.0% | 0.08% | -2.4% |
| Q1 2019 | $281,000 | +9.8% | 6,721 | +0.2% | 0.08% | +9.0% |
| Q4 2018 | $256,000 | -21.0% | 6,706 | -16.8% | 0.08% | +9.9% |
| Q3 2018 | $324,000 | +1.2% | 8,060 | +1.6% | 0.07% | -7.8% |
| Q2 2018 | $320,000 | +6.0% | 7,935 | +2.8% | 0.08% | +30.5% |
| Q1 2018 | $302,000 | +19.8% | 7,719 | +8.7% | 0.06% | -1.7% |
| Q4 2017 | $252,000 | -23.9% | 7,104 | -12.9% | 0.06% | -25.9% |
| Q3 2017 | $331,000 | -4.9% | 8,154 | +0.9% | 0.08% | +11.0% |
| Q2 2017 | $348,000 | +9.4% | 8,079 | +7.3% | 0.07% | 0.0% |
| Q1 2017 | $318,000 | -4.8% | 7,532 | -13.1% | 0.07% | +1.4% |
| Q4 2016 | $334,000 | -16.9% | 8,670 | -8.1% | 0.07% | -25.0% |
| Q3 2016 | $402,000 | +0.8% | 9,439 | +2.4% | 0.10% | -1.0% |
| Q2 2016 | $399,000 | -1.7% | 9,217 | -7.9% | 0.10% | -4.0% |
| Q1 2016 | $406,000 | -7.1% | 10,007 | -7.5% | 0.10% | -3.8% |
| Q4 2015 | $437,000 | -8.2% | 10,819 | -12.7% | 0.10% | -15.3% |
| Q3 2015 | $476,000 | -14.7% | 12,389 | -7.6% | 0.12% | -13.9% |
| Q2 2015 | $558,000 | -11.3% | 13,409 | -1.5% | 0.14% | -11.1% |
| Q1 2015 | $629,000 | -10.3% | 13,619 | -17.0% | 0.16% | -11.0% |
| Q4 2014 | $701,000 | +47.6% | 16,410 | +58.7% | 0.18% | +28.2% |
| Q3 2014 | $475,000 | -14.1% | 10,343 | 0.0% | 0.14% | -14.5% |
| Q2 2014 | $553,000 | -3.3% | 10,343 | -3.3% | 0.17% | -11.2% |
| Q1 2014 | $572,000 | +41.9% | 10,698 | +41.8% | 0.19% | +37.5% |
| Q4 2013 | $403,000 | +82.4% | 7,543 | +71.5% | 0.14% | +97.1% |
| Q3 2013 | $221,000 | -31.2% | 4,398 | -31.5% | 0.07% | -38.4% |
| Q2 2013 | $321,000 | – | 6,423 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |